Clinical Trial Progress and Analyst Endorsement Spark Short-Term Rebound for Olema Pharmaceuticals
Headquartered in California, Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals Inc. (OLMA)
Market is closed
Sector: Investment Advice
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 5,295,893 | $22,560,504 | 0.81% | |
| 2. | Woodline Partners Michael Rockefeller And Karl Kroeker | 3,505,893 | $14,935,104 | +138% | 0.08% |
| 3. | Deep Track Capital David Kroin | 3,442,833 | $14,666,469 | 0.47% | |
| 4. | Logos Capital Arsani William | 3,208,875 | $13,669,808 | 1.51% | |
| 5. | BioImpact Capital Mpm Capital | 2,378,762 | $10,133,526 | -19% | 1.76% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.76 | 300,000 | $1,727,370.00 | 7,800,000 | 2025-01-08 | Filing | |
| $6.75 | 700,761 | $4,730,136.75 | 700,761 | 2024-12-13 | Filing | |
| $6.75 | 700,761 | $4,730,136.75 | 1,408,875 | 2024-12-17 | Filing | |
| $13.09 | 50,000 | $654,250.00 | 1,800,000 | 2023-12-05 | Filing | |
| $14.95 | 50,000 | $747,480.00 | 1,750,000 | 2023-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.75 | 700,761 | $4,730,136.75 | 0 | 2024-12-13 | Filing | |
| $6.75 | 700,761 | $4,730,136.75 | 0 | 2024-12-17 | Filing | |
| $9.39 | 179 | $1,680.81 | 764,140 | 2024-12-11 | Filing | |
| $8.66 | 7,958 | $68,916.28 | 764,319 | 2024-12-11 | Filing | |
| $9.37 | 8,256 | $77,358.72 | 772,277 | 2024-12-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,843,954 | $29,155,244 | 3.65% | |
| 2. | 6,764,172 | $28,815,373 | 1.23% | |
| 3. | 4,605,109 | $19,617,764 | 0% | |
| 4. | 3,266,999 | $13,917,415 | 0% | |
| 5. | 3,022,784 | $12,892,174 | 0.01% |
News See All
11 Best Short-Term Stocks to Invest in
The latter half of the 2025 market is caught between conflicting signals.
H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance
On May 28, Olema Pharmaceuticals, Inc.
15 Small-Cap Stocks with High Potential
In this article, we will take a look at the 15 small-cap stocks with high potential.
12 Best Performing NASDAQ Stocks in 2023
In this piece, we will take a look at the 12 best performing NASDAQ stocks in 2023.
5 Best Performing Biotech Stocks in 2023
In this piece, we will take a look at the five best performing biotechnology stocks in 2023.
8 Stocks in Eashwar Krishnan's Tybourne Capital Management Portfolio
In this article, we will take a look at some of the stocks in Eashwar Krishnan’s Tybourne Capital Management portfolio.
5 Best Biotech Stocks to Buy According to Mark Lampert's Biotechnology Value Fund
In this article, we discuss the 5 best biotech stocks to buy according to Mark Lampert.
5 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
Below is the list of 5 pharma stocks to buy according to Mark Lampert’s Biotechnology Value Fund.
Hedge Fund and Insider Trading News: York Capital Management, Point72 Asset Management, Elliott Advisors, Cresco Labs Inc (CRLBF), Estee Lauder Companies Inc (EL), and More
Blackstart Capital, which listed $319 million under management on a recent disclosure form, has terminated its registration with the Securities and Exchange Commission.
Billionaire Hedge Funds
